A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P. Anoop Chandran, Henning Zelba, Elisa Rusch, Cécile Gouttefangeas, Daniel J. Kowalewski, Moreno Di Marco, Sebastian P. Haen, Juliane S. Walz, Yamel Cardona Gloria, Johanna Bödder, Jill-Marie Schertel, Antje Tunger, Luise Müller, Maximilian Kießler, Rebekka Wehner, Marc Schmitz, Meike Jakobi, Nicole Schneiderhan-Marra, Reinhild Klein, Karoline Laske, Kerstin Artzner, Linus Backert, Heiko Schuster, Johannes Schwenck, Alexander N. R. Weber, Bernd J. Pichler, Manfred Kneilling, Christian la Fougère, Stephan Forchhammer, Gisela Metzler, Jürgen Bauer, Benjamin Weide, Wilfried Schippert, Stefan Stevanović, Markus W. Löffler

Open source

DOI: 10.1186/s40425-019-0796-5
Published: 2019-11-15
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40425-019-0796-5,
  title = {A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer},
  author = {Hans-Georg Rammensee and Karl-Heinz Wiesmüller and P. Anoop Chandran and Henning Zelba and Elisa Rusch and Cécile Gouttefangeas and Daniel J. Kowalewski and Moreno Di Marco and Sebastian P. Haen and Juliane S. Walz and Yamel Cardona Gloria and Johanna Bödder and Jill-Marie Schertel and Antje Tunger and Luise Müller and Maximilian Kießler and Rebekka Wehner and Marc Schmitz and Meike Jakobi and Nicole Schneiderhan-Marra and Reinhild Klein and Karoline Laske and Kerstin Artzner and Linus Backert and Heiko Schuster and Johannes Schwenck and Alexander N. R. Weber and Bernd J. Pichler and Manfred Kneilling and Christian la Fougère and Stephan Forchhammer and Gisela Metzler and Jürgen Bauer and Benjamin Weide and Wilfried Schippert and Stefan Stevanović and Markus W. Löffler},
  year = {2019},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1186/s40425-019-0796-5},
  url = {https://doi.org/10.1186/s40425-019-0796-5}
}

RIS

TY  - JOUR
TI  - A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
AU  - Hans-Georg Rammensee
AU  - Karl-Heinz Wiesmüller
AU  - P. Anoop Chandran
AU  - Henning Zelba
AU  - Elisa Rusch
AU  - Cécile Gouttefangeas
AU  - Daniel J. Kowalewski
AU  - Moreno Di Marco
AU  - Sebastian P. Haen
AU  - Juliane S. Walz
AU  - Yamel Cardona Gloria
AU  - Johanna Bödder
AU  - Jill-Marie Schertel
AU  - Antje Tunger
AU  - Luise Müller
AU  - Maximilian Kießler
AU  - Rebekka Wehner
AU  - Marc Schmitz
AU  - Meike Jakobi
AU  - Nicole Schneiderhan-Marra
AU  - Reinhild Klein
AU  - Karoline Laske
AU  - Kerstin Artzner
AU  - Linus Backert
AU  - Heiko Schuster
AU  - Johannes Schwenck
AU  - Alexander N. R. Weber
AU  - Bernd J. Pichler
AU  - Manfred Kneilling
AU  - Christian la Fougère
AU  - Stephan Forchhammer
AU  - Gisela Metzler
AU  - Jürgen Bauer
AU  - Benjamin Weide
AU  - Wilfried Schippert
AU  - Stefan Stevanović
AU  - Markus W. Löffler
PY  - 2019
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1186/s40425-019-0796-5
UR  - https://doi.org/10.1186/s40425-019-0796-5
ER  -

APA

Rammensee, H., Wiesmüller, K., Chandran, P. A., Zelba, H., Rusch, E., Gouttefangeas, C., Kowalewski, D. J., Marco, M. D., Haen, S. P., Walz, J. S., Gloria, Y. C., Bödder, J., Schertel, J., Tunger, A., Müller, L., Kießler, M., Wehner, R., Schmitz, M., Jakobi, M., Schneiderhan-Marra, N., Klein, R., Laske, K., Artzner, K., Backert, L., Schuster, H., Schwenck, J., Weber, A. N. R., Pichler, B. J., Kneilling, M., Fougère, C. L., Forchhammer, S., Metzler, G., Bauer, J., Weide, B., Schippert, W., Stevanović, S., & Löffler, M. W. (2019). A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-019-0796-5

Source records

crossref · retrieved 2026-09-25T22:18:52.175Z